ID   GRSF1_HUMAN             Reviewed;         480 AA.
AC   Q12849; B3KPW0; Q4W5S5; Q6ZST3; Q8IWD6; Q8NBD2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   07-APR-2021, entry version 179.
DE   RecName: Full=G-rich sequence factor 1;
DE            Short=GRSF-1;
DE   Flags: Precursor;
GN   Name=GRSF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8036161; DOI=10.1093/nar/22.12.2334;
RA   Qian Z., Wilusz J.;
RT   "GRSF-1: a poly(A)+ mRNA binding protein which interacts with a conserved
RT   G-rich element.";
RL   Nucleic Acids Res. 22:2334-2343(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, Caudate nucleus, Cerebellum, Prostate, and Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT TYR-277.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 177-188; 243-253 AND 318-325, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RA   Bienvenut W.V., Vousden K.H., Lukashchuk N.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-335, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   FUNCTION, RNA-BINDING, AND SUBCELLULAR LOCATION.
RX   PubMed=23473033; DOI=10.1016/j.cmet.2013.02.006;
RA   Antonicka H., Sasarman F., Nishimura T., Paupe V., Shoubridge E.A.;
RT   "The mitochondrial RNA-binding protein GRSF1 localizes to RNA granules and
RT   is required for posttranscriptional mitochondrial gene expression.";
RL   Cell Metab. 17:386-398(2013).
RN   [13]
RP   FUNCTION, RNA-BINDING, SUBCELLULAR LOCATION (ISOFORMS 1 AND 2), AND
RP   INTERACTION WITH TRMT10C.
RX   PubMed=23473034; DOI=10.1016/j.cmet.2013.02.005;
RA   Jourdain A.A., Koppen M., Wydro M., Rodley C.D., Lightowlers R.N.,
RA   Chrzanowska-Lightowlers Z.M., Martinou J.C.;
RT   "GRSF1 regulates RNA processing in mitochondrial RNA granules.";
RL   Cell Metab. 17:399-410(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   IDENTIFICATION IN A COMPLEX WITH DDX28; DHX30; FASTKD2 AND FASTKD5,
RP   SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25683715; DOI=10.1016/j.celrep.2015.01.030;
RA   Antonicka H., Shoubridge E.A.;
RT   "Mitochondrial RNA granules are centers for post-transcriptional RNA
RT   processing and ribosome biogenesis.";
RL   Cell Rep. 10:920-932(2015).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   FUNCTION, RNA-BINDING, SUBCELLULAR LOCATION, INTERACTION WITH PNPT1 AND
RP   SUPV3L1, DOMAIN, IDENTIFICATION BY MASS SPECTROMETRY, AND MUTAGENESIS OF
RP   GLN-155; TRP-159; GLU-223; ARG-255; TYR-259; GLU-320; ARG-406; PHE-410 AND
RP   GLU-470.
RX   PubMed=29967381; DOI=10.1038/s41467-018-05007-9;
RA   Pietras Z., Wojcik M.A., Borowski L.S., Szewczyk M., Kulinski T.M.,
RA   Cysewski D., Stepien P.P., Dziembowski A., Szczesny R.J.;
RT   "Dedicated surveillance mechanism controls G-quadruplex forming non-coding
RT   RNAs in human mitochondria.";
RL   Nat. Commun. 9:2558-2558(2018).
RN   [18] {ECO:0007744|PDB:2LMI}
RP   STRUCTURE BY NMR OF 140-245.
RA   Dutta S.K., Serrano P., Geralt M., Wuthrich K.;
RT   "NMR structure of the human RNA binding protein BC040485.";
RL   Submitted (DEC-2011) to the PDB data bank.
RN   [19] {ECO:0007744|PDB:4QU6, ECO:0007744|PDB:4QU7}
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 140-245 IN COMPLEX WITH RNA.
RG   Joint Center for Structural Genomics (JCSG), Partnership for T-Cell Biology (TCELL);
RT   "Crystal structure of a G-rich RNA sequence binding factor 1 (GRSF1) from
RT   Homo sapiens at 1.75 A resolution.";
RL   Submitted (JUL-2014) to the PDB data bank.
CC   -!- FUNCTION: Regulator of post-transcriptional mitochondrial gene
CC       expression, required for assembly of the mitochondrial ribosome and for
CC       recruitment of mRNA and lncRNA. Binds RNAs containing the 14 base G-
CC       rich element. Preferentially binds RNAs transcribed from three
CC       contiguous genes on the light strand of mtDNA, the ND6 mRNA, and the
CC       long non-coding RNAs for MT-CYB and MT-ND5, each of which contains
CC       multiple consensus binding sequences (PubMed:23473033, PubMed:23473034,
CC       PubMed:29967381). Involved in the degradosome-mediated decay of non-
CC       coding mitochondrial transcripts (MT-ncRNA) and tRNA-like molecules
CC       (PubMed:29967381). Acts by unwinding G-quadruplex RNA structures in MT-
CC       ncRNA, thus facilitating their degradation by the degradosome
CC       (PubMed:29967381). G-quadruplexes (G4) are non-canonical 4 stranded
CC       structures formed by transcripts from the light strand of mtDNA
CC       (PubMed:29967381). {ECO:0000269|PubMed:23473033,
CC       ECO:0000269|PubMed:23473034, ECO:0000269|PubMed:29967381}.
CC   -!- SUBUNIT: Monomer. Found in a complex with DDX28, DHX30, FASTKD2 and
CC       FASTKD5 (PubMed:25683715). Interacts with the mitochondrial RNase P
CC       complex subunit TRMT10C/MRPP1 (PubMed:23473034). Interacts with the 2
CC       components of the mitochondrial degradosome complex, PNPT1 and SUPV3L1,
CC       in an RNA-dependent manner (PubMed:29967381).
CC       {ECO:0000269|PubMed:23473034, ECO:0000269|PubMed:25683715,
CC       ECO:0000269|PubMed:29967381}.
CC   -!- INTERACTION:
CC       Q12849; O75832: PSMD10; NbExp=4; IntAct=EBI-1054150, EBI-752185;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Mitochondrion matrix
CC       {ECO:0000269|PubMed:23473033, ECO:0000269|PubMed:23473034,
CC       ECO:0000269|PubMed:25683715, ECO:0000269|PubMed:29967381}.
CC       Note=Localizes to mitochondrial RNA granules found in close proximity
CC       to the mitochondrial nucleoids. {ECO:0000269|PubMed:23473033,
CC       ECO:0000269|PubMed:23473034, ECO:0000269|PubMed:25683715}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm
CC       {ECO:0000269|PubMed:23473034}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q12849-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q12849-5; Sequence=VSP_043118;
CC   -!- DOMAIN: The RRM domains mediate RNA-binding.
CC       {ECO:0000269|PubMed:29967381}.
CC   -!- MISCELLANEOUS: Depletion of GRSF1 by siRNA results in a combined OXPHOS
CC       assembly defect, with the prominent loss of complexes I, III, IV, and
CC       V. It also leads to altered steady-state levels of mitochondrial rRNAs
CC       and mRNAs.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC95399.1; Type=Miscellaneous discrepancy; Note=Unlikely isoform. Aberrant splice sites.; Evidence={ECO:0000305};
CC       Sequence=AAH40485.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC       Sequence=AAY40942.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAC03513.1; Type=Miscellaneous discrepancy; Note=Unlikely isoform. Aberrant splice sites.; Evidence={ECO:0000305};
CC       Sequence=BAC86863.1; Type=Miscellaneous discrepancy; Note=Unlikely isoform. Aberrant splice sites.; Evidence={ECO:0000305};
CC       Sequence=EAX05634.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U07231; AAC95399.1; ALT_SEQ; mRNA.
DR   EMBL; AK056891; BAG51822.1; -; mRNA.
DR   EMBL; AK090755; BAC03513.1; ALT_SEQ; mRNA.
DR   EMBL; AK094806; BAG52934.1; -; mRNA.
DR   EMBL; AK095799; BAG53131.1; -; mRNA.
DR   EMBL; AK097055; BAG53414.1; -; mRNA.
DR   EMBL; AK127161; BAC86863.1; ALT_SEQ; mRNA.
DR   EMBL; AC021989; AAY40942.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471057; EAX05631.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX05634.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC040485; AAH40485.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS47069.1; -. [Q12849-1]
DR   CCDS; CCDS47070.1; -. [Q12849-5]
DR   PIR; S48081; S48081.
DR   RefSeq; NP_001091947.1; NM_001098477.1. [Q12849-5]
DR   RefSeq; NP_002083.3; NM_002092.3. [Q12849-1]
DR   RefSeq; XP_011530199.1; XM_011531897.2. [Q12849-5]
DR   PDB; 2LMI; NMR; -; A=140-245.
DR   PDB; 4QU6; X-ray; 1.75 A; A=140-245.
DR   PDB; 4QU7; X-ray; 2.50 A; A/B/C/D=400-480.
DR   PDBsum; 2LMI; -.
DR   PDBsum; 4QU6; -.
DR   PDBsum; 4QU7; -.
DR   SMR; Q12849; -.
DR   BioGRID; 109182; 445.
DR   CORUM; Q12849; -.
DR   IntAct; Q12849; 23.
DR   STRING; 9606.ENSP00000254799; -.
DR   iPTMnet; Q12849; -.
DR   MetOSite; Q12849; -.
DR   PhosphoSitePlus; Q12849; -.
DR   SwissPalm; Q12849; -.
DR   BioMuta; GRSF1; -.
DR   DMDM; 215274142; -.
DR   EPD; Q12849; -.
DR   jPOST; Q12849; -.
DR   MassIVE; Q12849; -.
DR   MaxQB; Q12849; -.
DR   PaxDb; Q12849; -.
DR   PeptideAtlas; Q12849; -.
DR   PRIDE; Q12849; -.
DR   ProteomicsDB; 58982; -. [Q12849-1]
DR   ProteomicsDB; 58983; -. [Q12849-5]
DR   Antibodypedia; 24367; 150 antibodies.
DR   Ensembl; ENST00000254799; ENSP00000254799; ENSG00000132463. [Q12849-1]
DR   Ensembl; ENST00000502323; ENSP00000425430; ENSG00000132463. [Q12849-5]
DR   GeneID; 2926; -.
DR   KEGG; hsa:2926; -.
DR   UCSC; uc010iia.2; human. [Q12849-1]
DR   CTD; 2926; -.
DR   DisGeNET; 2926; -.
DR   GeneCards; GRSF1; -.
DR   HGNC; HGNC:4610; GRSF1.
DR   HPA; ENSG00000132463; Tissue enhanced (skeletal).
DR   MIM; 604851; gene.
DR   neXtProt; NX_Q12849; -.
DR   OpenTargets; ENSG00000132463; -.
DR   PharmGKB; PA29003; -.
DR   VEuPathDB; HostDB:ENSG00000132463.13; -.
DR   eggNOG; KOG4211; Eukaryota.
DR   GeneTree; ENSGT00940000158529; -.
DR   HOGENOM; CLU_032003_0_0_1; -.
DR   InParanoid; Q12849; -.
DR   OrthoDB; 603679at2759; -.
DR   PhylomeDB; Q12849; -.
DR   TreeFam; TF316157; -.
DR   PathwayCommons; Q12849; -.
DR   Reactome; R-HSA-192823; Viral mRNA Translation.
DR   SIGNOR; Q12849; -.
DR   BioGRID-ORCS; 2926; 195 hits in 1006 CRISPR screens.
DR   ChiTaRS; GRSF1; human.
DR   GenomeRNAi; 2926; -.
DR   Pharos; Q12849; Tbio.
DR   PRO; PR:Q12849; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q12849; protein.
DR   Bgee; ENSG00000132463; Expressed in female gonad and 244 other tissues.
DR   ExpressionAtlas; Q12849; baseline and differential.
DR   Genevisible; Q12849; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IBA:GO_Central.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IBA:GO_Central.
DR   GO; GO:0035770; C:ribonucleoprotein granule; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; TAS:ProtInc.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0016331; P:morphogenesis of embryonic epithelium; IEA:Ensembl.
DR   GO; GO:0006378; P:mRNA polyadenylation; TAS:ProtInc.
DR   GO; GO:0000962; P:positive regulation of mitochondrial RNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0043484; P:regulation of RNA splicing; IBA:GO_Central.
DR   GO; GO:0008033; P:tRNA processing; IEA:UniProtKB-KW.
DR   CDD; cd12730; RRM1_GRSF1; 1.
DR   CDD; cd12505; RRM2_GRSF1; 1.
DR   CDD; cd12733; RRM3_GRSF1; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR034424; GRSF-1_RRM2.
DR   InterPro; IPR033106; GRSF1.
DR   InterPro; IPR034425; GRSF1_RRM1.
DR   InterPro; IPR034426; GRSF1_RRM3.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR13976:SF42; PTHR13976:SF42; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 2.
DR   PROSITE; PS50102; RRM; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Direct protein sequencing;
KW   Mitochondrion; mRNA processing; Phosphoprotein; Reference proteome; Repeat;
KW   RNA-binding; Transit peptide; tRNA processing.
FT   TRANSIT         1..117
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           118..480
FT                   /note="G-rich sequence factor 1"
FT                   /id="PRO_0000081597"
FT   DOMAIN          122..246
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          250..326
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          401..480
FT                   /note="RRM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   COMPBIAS        55..111
FT                   /note="Ala-rich"
FT   MOD_RES         244
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         335
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   VAR_SEQ         1..162
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043118"
FT   VARIANT         277
FT                   /note="D -> Y (in dbSNP:rs17854012)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_047537"
FT   MUTAGEN         155
FT                   /note="Q->A: Impairs RNA-binding and melting of G-
FT                   quadruplex RNA structures; when associated with A-159; A-
FT                   223; A-255; A-259; A-320; A-406; A-410 and A-470."
FT   MUTAGEN         159
FT                   /note="W->A: Impairs RNA-binding and melting of G-
FT                   quadruplex RNA structures; when associated with A-155; A-
FT                   223; A-255; A-259; A-320; A-406; A-410 and A-470."
FT   MUTAGEN         223
FT                   /note="E->A: Impairs RNA-binding and melting of G-
FT                   quadruplex RNA structures; when associated with A-155; A-
FT                   159; A-255; A-259; A-320; A-406; A-410 and A-470."
FT   MUTAGEN         255
FT                   /note="R->A: Impairs RNA-binding and melting of G-
FT                   quadruplex RNA structures; when associated with A-155; A-
FT                   159; A-223; A-259; A-320; A-406; A-410 and A-470."
FT   MUTAGEN         259
FT                   /note="Y->A: Impairs RNA-binding and melting of G-
FT                   quadruplex RNA structures; when associated with A-155; A-
FT                   159; A-223; A-255; A-320; A-406; A-410 and A-470."
FT   MUTAGEN         320
FT                   /note="E->A: Impairs RNA-binding and melting of G-
FT                   quadruplex RNA structures; when associated with A-155; A-
FT                   159; A-223; A-255; A-259; A-406; A-410 and A-470."
FT   MUTAGEN         406
FT                   /note="R->A: Impairs RNA-binding and melting of G-
FT                   quadruplex RNA structures; when associated with A-155; A-
FT                   159; A-223; A-255; A-259; A-320; A-410 and A-470."
FT   MUTAGEN         410
FT                   /note="F->A: Impairs RNA-binding and melting of G-
FT                   quadruplex RNA structures; when associated with A-155; A-
FT                   159; A-223; A-255; A-259; A-320; A-406 and A-470."
FT   MUTAGEN         470
FT                   /note="E->A: Impairs RNA-binding and melting of G-
FT                   quadruplex RNA structures; when associated with A-155; A-
FT                   159; A-223; A-255; A-259; A-320; A-406 and A-410."
FT   CONFLICT        264
FT                   /note="K -> E (in Ref. 2; BAC86863)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        365..366
FT                   /note="DI -> VF (in Ref. 1; AAC95399)"
FT                   /evidence="ECO:0000305"
FT   STRAND          150..156
FT                   /evidence="ECO:0007744|PDB:4QU6"
FT   HELIX           163..169
FT                   /evidence="ECO:0007744|PDB:4QU6"
FT   TURN            170..172
FT                   /evidence="ECO:0007744|PDB:4QU6"
FT   HELIX           178..181
FT                   /evidence="ECO:0007744|PDB:4QU6"
FT   STRAND          182..186
FT                   /evidence="ECO:0007744|PDB:4QU6"
FT   STRAND          192..202
FT                   /evidence="ECO:0007744|PDB:4QU6"
FT   HELIX           203..210
FT                   /evidence="ECO:0007744|PDB:4QU6"
FT   TURN            211..214
FT                   /evidence="ECO:0007744|PDB:4QU6"
FT   STRAND          215..217
FT                   /evidence="ECO:0007744|PDB:4QU6"
FT   STRAND          220..226
FT                   /evidence="ECO:0007744|PDB:4QU6"
FT   HELIX           230..242
FT                   /evidence="ECO:0007744|PDB:4QU6"
FT   STRAND          402..406
FT                   /evidence="ECO:0007744|PDB:4QU7"
FT   HELIX           414..421
FT                   /evidence="ECO:0007744|PDB:4QU7"
FT   STRAND          427..434
FT                   /evidence="ECO:0007744|PDB:4QU7"
FT   STRAND          439..446
FT                   /evidence="ECO:0007744|PDB:4QU7"
FT   HELIX           450..456
FT                   /evidence="ECO:0007744|PDB:4QU7"
FT   HELIX           457..459
FT                   /evidence="ECO:0007744|PDB:4QU7"
FT   STRAND          470..476
FT                   /evidence="ECO:0007744|PDB:4QU7"
SQ   SEQUENCE   480 AA;  53126 MW;  E09EE4E70212A70F CRC64;
     MAGTRWVLGA LLRGCGCNCS SCRRTGAACL PFYSAAGSIP SGVSGRRRLL LLLGAAAAAA
     SQTRGLQTGP VPPGRLAGPP AVATSAAAAA AASYSALRAS LLPQSLAAAA AVPTRSYSQE
     SKTTYLEDLP PPPEYELAPS KLEEEVDDVF LIRAQGLPWS CTMEDVLNFF SDCRIRNGEN
     GIHFLLNRDG KRRGDALIEM ESEQDVQKAL EKHRMYMGQR YVEVYEINNE DVDALMKSLQ
     VKSSPVVNDG VVRLRGLPYS CNEKDIVDFF AGLNIVDITF VMDYRGRRKT GEAYVQFEEP
     EMANQALLKH REEIGNRYIE IFPSRRNEVR THVGSYKGKK IASFPTAKYI TEPEMVFEEH
     EVNEDIQPMT AFESEKEIEL PKEVPEKLPE AADFGTTSSL HFVHMRGLPF QANAQDIINF
     FAPLKPVRIT MEYSSSGKAT GEADVHFETH EDAVAAMLKD RSHVHHRYIE LFLNSCPKGK
//
